1. Six years of experience with sacral nerve stimulation for fecal incontinence
- Author
-
Hanne B. Michelsen, Lilli Lundby, Mark Thompson-Fawcett, Søren Laurberg, Steen Buntzen, and Klaus Krogh
- Subjects
musculoskeletal diseases ,Adult ,Male ,medicine.medical_specialty ,Percutaneous ,Functional failure ,Lumbosacral Plexus ,Anal Canal ,Electric Stimulation Therapy ,Single Center ,medicine ,Fecal incontinence ,Humans ,Positive test ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Gastroenterology ,Retrospective cohort study ,General Medicine ,Middle Aged ,musculoskeletal system ,Anal physiology ,Surgery ,Electrodes, Implanted ,body regions ,Treatment Outcome ,Sacral nerve stimulation ,Retreatment ,Female ,medicine.symptom ,business ,Fecal Incontinence - Abstract
PURPOSE: Sacral nerve stimulation is one of many new surgical modalities for fecal incontinence. Short-term results from sacral nerve stimulation have been more encouraging than those from other modalities. The aim of this study was to report the outcome of percutaneous nerve evaluation tests and sacral nerve stimulation for the treatment of fecal incontinence from a single center covering a period of 6 years since the procedure was introduced. METHODS: All of the candidates for a percutaneous nerve evaluation test and sacral nerve stimulation seen at our anal physiology unit between March 2001 and March 2007 were included in the study. RESULTS: A total of 177 patients with fecal incontinence (160 females), median age 59.5 (range, 27-88) years, underwent a percutaneous nerve evaluation test. Of these patients, 142 (80%) had a positive test, including 21 of 25 (84%) patients who required a repeat percutaneous nerve evaluation test. Because of a functional failure, 16 patients underwent a revision of the permanent electrode, 7 of whom (44%) were satisfied with the functional result after the revision. Of 126 patients, 15 (12%) have undergone an explantation, with an infection rate of only 1.6%. Overall, after a median follow-up of 24 (range, 3-72) months, the median Wexner incontinence score decreased from 16 (range, 6-20) to 10 (range, 0-20) (P < .0001). In the 10 patients who underwent at least 6 years of treatment, the effect was sustained, as the median Wexner incontinence score decreased from 20 (range, 12-20) to 7 (range, 2-11) (P < .0001). CONCLUSION: Sacral nerve stimulation is a simple, safe, and minimally invasive technique with low morbidity and excellent results, which appear to be maintained for the first 6 years after the procedure. For patients who underwent the treatment, median Wexner incontinence score decreased significantly after a median follow-up of 24 (range, 3-72) months. Twelve percent were explanted. The infection rate was 1.6%.
- Published
- 2010